Piotr Lukasz Rutkowski (Piotr Rutkowski, Anna M Czarnecka, Piotr Ł Rutkowski, Piotr R Rutkowski, Piotr L Rutkowski, Piotr Łukasz Rutkowski)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 111

Top Venues

Cancers

International journal of molecular sciences

Journal of clinical medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Centrum Onkologii-Instytut im Marii Skłodowskiej-Curie Warszawa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centrum Onkologii-Instytut im Marii Skłodowskiej-Curie Warszawa Aug 01 1998

Poland

Head of Department :: Department of Soft Tissue/Bone Sarcoma and Melanoma

Publications

Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Anna Małgorzata Czarnecka, Paulina Chmiel, Piotr J Błoński, Piotr Lukasz Rutkowski
Establishing biomarkers for soft tissue sarcomas. Expert review of anticancer therapy (2024)
Palina Skipar, Mritunjoy Dey, Jakub Piątkowski, Dorota Sulejczak, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma. International journal of molecular sciences 25 (6) (2024)
Piotr J Błoński, Anna Małgorzata Czarnecka, Krzysztof Ostaszewski, Anna Szumera-Ciećkiewicz, Piotr Lukasz Rutkowski
Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma. Biomedicines 12 (3) (2024)
Paulina Chmiel, Maria Krotewicz, Anna Szumera-Ciećkiewicz, Ewa Bartnik, Anna M Czarnecka, Piotr Lukasz Rutkowski
Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma. Current oncology (Toronto, Ont.) 31 (1) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Kamil Jozef Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Domenico Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Lukasz Rutkowski, Yacoub A Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michał Fiedorowicz, Anna Małgorzata Czarnecka
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma. Current oncology (Toronto, Ont.) 31 (2) (2024)
Palina Skipar, Mritunjoy Dey, Jakub Piątkowski, Dorota Sulejczak, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma. International journal of molecular sciences 25 (6) (2024)
Paulina Chmiel, Maria Krotewicz, Anna Szumera-Ciećkiewicz, Ewa Bartnik, Anna M Czarnecka, Piotr Lukasz Rutkowski
Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma. Current oncology (Toronto, Ont.) 31 (1) (2024)
André B P van Kuilenburg, Albiruni Abdul Razak, Matthew H Taylor, Todd M Bauer, Breelyn A Wilky, Javier Martín-Broto, Alejandro Falcón Gonzalez, Piotr Lukasz Rutkowski, Bartlomiej Szostakowski, Thierry Alcindor, Ramy R Saleh, Sofia Genta, Silvia Stacchiotti, Michiel Adreanus van de Sande, Andrew J Wagner, Nicholas M Bernthal, Lara E Davis, Jacqueline Vuky, Christopher Tait, Bahar Matin, Supraja Narasimhan, Maitreyi G Sharma, Rodrigo Ruiz-Soto, Matthew L Sherman, William D Tap
CSF1R Inhibition in Patients With Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase 1 Study of Vimseltinib. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kamil Jozef Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Domenico Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Lukasz Rutkowski, Yacoub A Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michał Fiedorowicz, Anna Małgorzata Czarnecka
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma. Current oncology (Toronto, Ont.) 31 (2) (2024)
Paweł Sobczuk, Michał Cholewiński, Piotr Lukasz Rutkowski
Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma. Expert opinion on pharmacotherapy (2024)
Kamil Jozef Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Domenico Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Lukasz Rutkowski, Yacoub A Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michał Fiedorowicz, Anna Małgorzata Czarnecka
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma. Current oncology (Toronto, Ont.) 31 (2) (2024)
Paweł Sobczuk, Michał Cholewiński, Piotr Lukasz Rutkowski
Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma. Expert opinion on pharmacotherapy (2024)
Anna Małgorzata Czarnecka, Paulina Chmiel, Piotr J Błoński, Piotr Lukasz Rutkowski
Establishing biomarkers for soft tissue sarcomas. Expert review of anticancer therapy 24 (6) (2024)
Paulina Chmiel, Maria Krotewicz, Anna Szumera-Ciećkiewicz, Ewa Bartnik, Anna M Czarnecka, Piotr Lukasz Rutkowski
Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma. Current oncology (Toronto, Ont.) 31 (1) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Paweł Sobczuk, Michał Cholewiński, Piotr Lukasz Rutkowski
Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma. Expert opinion on pharmacotherapy 25 (5) (2024)
Paulina Chmiel, Maria Krotewicz, Anna Szumera-Ciećkiewicz, Ewa Bartnik, Anna M Czarnecka, Piotr Lukasz Rutkowski
Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma. Current oncology (Toronto, Ont.) 31 (1) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Kamil Jozef Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Domenico Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Lukasz Rutkowski, Yacoub A Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michał Fiedorowicz, Anna Małgorzata Czarnecka
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma. Current oncology (Toronto, Ont.) 31 (2) (2024)
Palina Skipar, Mritunjoy Dey, Jakub Piątkowski, Dorota Sulejczak, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma. International journal of molecular sciences 25 (6) (2024)
Piotr J Błoński, Anna Małgorzata Czarnecka, Krzysztof Ostaszewski, Anna Szumera-Ciećkiewicz, Piotr Lukasz Rutkowski
Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma. Biomedicines 12 (3) (2024)
Kamil Jozef Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Domenico Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Lukasz Rutkowski, Yacoub A Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michał Fiedorowicz, Anna Małgorzata Czarnecka
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma. Current oncology (Toronto, Ont.) 31 (2) (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Anna Małgorzata Czarnecka, Paulina Chmiel, Piotr J Błoński, Piotr Lukasz Rutkowski
Establishing biomarkers for soft tissue sarcomas. Expert review of anticancer therapy 24 (6) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Dirk Schadendorf, Jason John Luke, Paolo Antonio Ascierto, Georgina V Long, Piotr Lukasz Rutkowski, Adnan Khattak, Michele Del Vecchio, Luis de la Cruz Merino, Jacek Mackiewicz, Vanna Chiarion Sileni, John M Kirkwood, Caroline Robert, Jean-Jacques Grob, Reinhard Dummer, Matteo S Carlino, Yujie Zhao, Mizuho Kalabis, Clemens Krepler, Alexander Eggermont, Richard A Scolyer
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for immunotherapy of cancer 12 (3) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Anna Małgorzata Czarnecka, Paulina Chmiel, Piotr J Błoński, Piotr Lukasz Rutkowski
Establishing biomarkers for soft tissue sarcomas. Expert review of anticancer therapy 24 (6) (2024)
Anna Szumera-Ciećkiewicz, Klaudia Bobak, Mateusz Jacek Spałek, Kamil Sokół, Michał Wągrodzki, Daria Owczarek, Monika Kawecka, Beata Puton, Hanna Kosela-Paterczyk, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas. Cancers 15 (11) (2023)
Marcin Ziętek, Pawel P Teterycz, Jędrzej Wierzbicki, Michał Jankowski, Manuela Las-Jankowska, Wojciech Zegarski, Janusz Piekarski, Dariusz Nejc, Kamil Drucis, Bozena Cybulska-Stopa, Wojciech Łobaziewicz, Katarzyna Galwas, Grażyna Kamińska-Winciorek, Marcin Zdzienicki, Tatsiana Sryukina, Anna Ziobro, Agnieszka Kluz, Anna Małgorzata Czarnecka, Piotr Lukasz Rutkowski
The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study. Cancers 15 (10) (2023)
Paweł Koczkodaj, Urszula Sulkowska, Joanna Didkowska, Piotr Lukasz Rutkowski, Marta Mańczuk
Melanoma Mortality Trends in 28 European Countries: A Retrospective Analysis for the Years 1960-2020. Cancers 15 (5) (2023)
Paweł Koczkodaj, Urszula Sulkowska, Joanna Didkowska, Piotr Lukasz Rutkowski, Marta Mańczuk
Melanoma Mortality Trends in 28 European Countries: A Retrospective Analysis for the Years 1960-2020. Cancers 15 (5) (2023)
Anna Maria Janik, Anna Terlecka, Mateusz Jacek Spałek, Kjetil Boye, Bartłomiej Szostakowski, Paulina Chmiel, Anna Szumera-Ciećkiewicz, Klaudia Bobak, Tomasz Świtaj, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors. Cancers 15 (24) (2023)
Natalia Banaszek, Dominika Kurpiewska, Katarzyna Kozak, Piotr Lukasz Rutkowski, Paweł Sobczuk
Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application. Journal of cancer research and clinical oncology (2023)
Anna Maria Janik, Anna Terlecka, Mateusz Jacek Spałek, Kjetil Boye, Bartłomiej Szostakowski, Paulina Chmiel, Anna Szumera-Ciećkiewicz, Klaudia Bobak, Tomasz Świtaj, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors. Cancers 15 (24) (2023)
Wiktoria Jędrys, Aleksandra Leśniak, Aneta Borkowska, Piotr Lukasz Rutkowski, Paweł Sobczuk
Brain metastases of sarcoma: a rare phenomenon in rare tumours. Journal of cancer research and clinical oncology (2023)
Michał Bereza, Mateusz Dembiński, Agnieszka E Zając, Jakub Piątkowski, Monika Dudzisz-Śledź, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Epigenetic Abnormalities in Chondrosarcoma. International journal of molecular sciences 24 (5) (2023)
Michał Bereza, Mateusz Dembiński, Agnieszka E Zając, Jakub Piątkowski, Monika Dudzisz-Śledź, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Epigenetic Abnormalities in Chondrosarcoma. International journal of molecular sciences 24 (5) (2023)
Filippo de Braud, Christophe Dooms, Rebecca S Heist, Celeste Lebbè, Martin Wermke, Anas Gazzah, Dirk Schadendorf, Piotr Lukasz Rutkowski, Juergen Wolf, Paolo Antonio Ascierto, Ignacio Gil-Bazo, Shumei Kato, Maria Wolodarski, Meredith A McKean, Eva Muñoz Couselo, Martin Sebastian, Armando Santoro, Vesselina Cooke, Luca Manganelli, Kitty Wan, Anil Gaur, Jaeyeon Kim, Giordano Caponigro, Xuân-Mai Couillebault, Helen Evans, Catarina D Campbell, Sumit Basu, Michele Moschetta, Adil I Daud
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Michał Bereza, Mateusz Dembiński, Agnieszka E Zając, Jakub Piątkowski, Monika Dudzisz-Śledź, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Epigenetic Abnormalities in Chondrosarcoma. International journal of molecular sciences 24 (5) (2023)
Piotr Lukasz Rutkowski, Hanna Koseła-Paterczyk
Perioperative Therapy in Melanoma: Several Questions Still Remain. Annals of surgical oncology (2023)
Anna M Czarnecka, Jacek Skoczylas, Ewa Bartnik, Tomasz Świtaj, Piotr Lukasz Rutkowski
Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions. Cancer management and research 15 (2023)
Piotr Lukasz Rutkowski, Anna M Czarnecka
Pembrolizumab for the adjuvant treatment of IIB or IIC melanoma. Expert review of anticancer therapy (2023)
Monika Dudzisz-Śledź, Monika Kondracka, Monika Rudzińska, Agnieszka E Zając, Wiktoria Firlej, Dorota Sulejczak, Aneta Borkowska, Bartlomiej Szostakowski, Anna Szumera-Ciećkiewicz, Jakub Piątkowski, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials. Cancers 15 (18) (2023)
Weronika Zając, Julia Dróżdż, Weronika Kisielewska, Weronika Karwowska, Monika Dudzisz-Śledź, Agnieszka E Zając, Aneta Borkowska, Anna Szumera-Ciećkiewicz, Bartlomiej Szostakowski, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials. Cancers 15 (15) (2023)
Marcin Kleibert, Iga Płachta, Anna Małgorzata Czarnecka, Mateusz Jacek Spałek, Anna Szumera-Ciećkiewicz, Piotr Lukasz Rutkowski
Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective. Cancers 14 (4) (2022)
Michał Wągrodzki, Andrzej Tysarowski, Katarzyna Seliga, Aneta Wojnowska, Maria Stepaniuk, Patrycja Castañeda Wysocka, Donata Makuła, Andrzej Pieńkowski, Bartłomiej Szostakowski, Renata Zub, Piotr Lukasz Rutkowski
Diagnostic Utility of Genetic and Immunohistochemical H3-3A Mutation Analysis in Giant Cell Tumour of Bone. International journal of molecular sciences 23 (2) (2022)
Paweł Sobczuk, Huber Bątruk, Paulina Wójcik, Krzysztof Iwaniak, Katarzyna Kozak, Piotr Lukasz Rutkowski
In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma. Journal of cancer research and clinical oncology (2022)
Che-Jui Lee, Elodie Modave, Bram Boeckx, Bernd Kasper, Steinar Aamdal, Michael G Leahy, Piotr Lukasz Rutkowski, Sebastian Bauer, Maria Debiec-Rychter, Raf M E Sciot, Diether Lambrechts, Agnieszka Wozniak, Patrick Schöffski
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial. International journal of molecular sciences 23 (10) (2022)
Paweł Rogala, Anna Małgorzata Czarnecka, Bozena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko, Marcin Ziętek, Robert Dziura, Ewa Rutkowska, Łukasz Galus, Natasza Kempa-Kamińska, Jacek Calik, Agata Sałek-Zań, Tomasz Zemełka, Wiesław Bal, Agnieszka Kamycka, Tomasz Świtaj, Grażyna Kamińska-Winciorek, Rafał Suwinski, Jacek Mackiewicz, Piotr Lukasz Rutkowski
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence. Journal of clinical medicine 11 (8) (2022)
Anna Małgorzata Czarnecka, Paweł Sobczuk, Paweł Rogala, Tomasz Świtaj, Joanna Placzke, Katarzyna Kozak, Anna Mariuk-Jarema, Mateusz Jacek Spałek, Monika Dudzisz-Śledź, Pawel P Teterycz, Aneta Borkowska, Piotr Lukasz Rutkowski
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence. Cancer immunology, immunotherapy : CII 71 (8) (2022)
Joanna Placzke, Pawel P Teterycz, Pietro Quaglino, Bozena Cybulska-Stopa, Marco Tucci, Marco Rubatto, Tomasz Skora, Valeria Interno, Magdalena Rosinska, Aneta Borkowska, Anna Szumera-Cieckiewicz, Mario Mandala, Piotr Lukasz Rutkowski
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report. Cancers 14 (23) (2022)
Anna Dawidowska, Paulina Jagodzinska-Mucha, Hanna Kosela-Paterczyk, Sylwia Jaczewska, Paweł Sobczuk, Monika Chelstowska, Maria Małgorzata Kowalska, Honorata Badziak-Sterczewska, Jan Poleszhuk, Piotr Lukasz Rutkowski, Iwona Lugowska
Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma. Cancers 14 (5) (2022)
Reinhard Dummer, Georgina V Long, Caroline Robert, Hussein A Tawbi, Keith T Flaherty, Paolo Antonio Ascierto, Paul D Nathan, Piotr Lukasz Rutkowski, Oleg Leonov, Caroline Dutriaux, Mario Mandala, Paul C Lorigan, Pier Francesco Ferrucci, Jean-Jacques Grob, Nicolas Meyer, Helen J Gogas, Daniil Stroyakovskiy, Ana M Arance, Jan C Brase, Steven Green, Tomas Haas, Aisha Masood, Eduard Gasal, Antoni Ribas, Dirk Schadendorf
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Joanna Placzke, Pawel P Teterycz, Pietro Quaglino, Bozena Cybulska-Stopa, Marco Tucci, Marco Rubatto, Tomasz Skora, Valeria Interno, Magdalena Rosinska, Aneta Borkowska, Anna Szumera-Cieckiewicz, Mario Mandala, Piotr Lukasz Rutkowski
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report. Cancers 14 (23) (2022)
Monika Dudzisz-Sledz, Paweł Sobczuk, Katarzyna Kozak, Tomasz Switaj, Hanna Kosela-Paterczyk, Anna Małgorzata Czarnecka, Slawomir Falkowski, Paweł Rogala, Tadeusz Morysinski, Mateusz Jacek Spałek, Marcin Zdzienicki, Tomasz Goryn, Marcin Zietek, Bozena Cybulska-Stopa, Stanisław Klek, Grażyna Kamińska-Winciorek, Barbara Ziolkowska, Anna Szumera-Cieckiewicz, Piotr Lukasz Rutkowski
Treatment of Locally Advanced Merkel Cell Carcinoma-A Multi-Center Study. Cancers 14 (2) (2022)
Carlos Henrique Barrios, Gilberto de Lima Lopes, Mastura Md Yusof, Fidel Rubagumya, Piotr Lukasz Rutkowski, Manju Sengar
Barriers in access to oncology drugs - a global crisis. Nature reviews. Clinical oncology (2022)
Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, James M G Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen J Gogas, Stéphane Dalle, Nicolas Meyer, Paolo Antonio Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C Hassel, Caroline Robert, Matteo S Carlino, Anna Maria Di Giacomo, Marcus O Butler, Eva Muñoz Couselo, Michael P Brown, Piotr Lukasz Rutkowski, Andrew M Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis de la Cruz Merino, Andre van der Westhuizen, Alexander M Menzies, Sandra Re, Tuba Bas, Veerle de Pril, Julia Braverman, Daniel J Tenney, Hao Tang, Georgina V Long
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Anna Małgorzata Czarnecka, Marcin Kleibert, Iga Płachta, Paweł Rogala, Michał Wągrodzki, Przemysław Leszek, Piotr Lukasz Rutkowski
Myocarditis Induced by Immunotherapy in Metastatic Melanoma-Review of Literature and Current Guidelines. Journal of clinical medicine 11 (17) (2022)
Maciej Stukan, Piotr Lukasz Rutkowski, Jeremy Smadja, Sylvie Bonvalot
Ultrasound-Guided Trans-Uterine Cavity Core Needle Biopsy of Uterine Myometrial Tumors to Differentiate Sarcoma from a Benign Lesion-Description of the Method and Review of the Literature. Diagnostics (Basel, Switzerland) 12 (6) (2022)
Paweł Rogala, Anna Małgorzata Czarnecka, Bożena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko, Marcin Ziętek, Robert Dziura, Ewa Rutkowska, Łukasz Galus, Natasza Kempa-Kamińska, Joanna Seredyńska, Wiesław Bal, Katarzyna Kozak, Anna Surus-Hyla, Tomasz Kubiatowski, Grażyna Kamińska-Winciorek, Rafał Suwinski, Jacek Mackiewicz, Piotr Lukasz Rutkowski
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. Cancers 14 (9) (2022)
Aneta Maria Borkowska, Anna Szumera-Ciećkiewicz, Bartłomiej Szostakowski, Andrzej Pieńkowski, Piotr Lukasz Rutkowski
Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence. Cancers 14 (9) (2022)
Piotr Lukasz Rutkowski, Andrzej Mackiewicz
Editorial to the Special Issue on Skin Cancer: The State of the Art. International journal of molecular sciences 23 (7) (2022)
Paweł Sobczuk, Katarzyna Kozak, Sylwia Kopeć, Paweł Rogala, Tomasz Świtaj, Hanna Kosela-Paterczyk, Aleksandra Gos, Andrzej Tysarowski, Piotr Lukasz Rutkowski
The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma. Cancers 14 (3) (2022)
Joanna Placzke, Pawel P Teterycz, Pietro Quaglino, Bozena Cybulska-Stopa, Marco Tucci, Marco Rubatto, Tomasz Skora, Valeria Interno, Magdalena Rosinska, Aneta Borkowska, Anna Szumera-Cieckiewicz, Mario Mandala, Piotr Lukasz Rutkowski
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report. Cancers 14 (23) (2022)
Joanna Placzke, Pawel P Teterycz, Pietro Quaglino, Bozena Cybulska-Stopa, Marco Tucci, Marco Rubatto, Tomasz Skora, Valeria Interno, Magdalena Rosinska, Aneta Borkowska, Anna Szumera-Cieckiewicz, Mario Mandala, Piotr Lukasz Rutkowski
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report. Cancers 14 (23) (2022)
Konrad Zasadziński, Mateusz Jacek Spałek, Piotr Lukasz Rutkowski
Modern Dressings in Prevention and Therapy of Acute and Chronic Radiation Dermatitis-A Literature Review. Pharmaceutics 14 (6) (2022)
Jason A Chesney, Antoni Ribas, Georgina V Long, Joanne M Jeter, Reinhard Dummer, Igor Puzanov, Christoph Hoeller, Thomas F Gajewski, Ralf Gutzmer, Piotr Lukasz Rutkowski, Lev Demidov, Petr Arenberger, Sang Joon Shin, Pier Francesco Ferrucci, Andrew M Haydon, John R Hyngstrom, Johannes V van Thienen, Sebastian Haferkamp, Josep Malvehy Guilera, Bernardo Leon Rapoport, Ari M VanderWalde, Scott J Diede, James R Anderson, Sheryl Treichel, Edward L Chan, Sumita Bhatta, Jennifer Gansert, Frank Stephen Hodi, Helen J Gogas
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Paolo Antonio Ascierto, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen J Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Marcello Curvietto, Ignacio Melero, Giuseppe Palmieri, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Monika Dudzisz-Śledź, Anna Klimczak, Elżbieta Bylina, Piotr Lukasz Rutkowski
Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients. Cancers 14 (12) (2022)
Mateusz Jacek Spałek, Aneta Maria Borkowska, Maria Telejko, Michał Wągrodzki, Daria Niebyłowska, Aldona Uzar, Magdalena Białobrzeska, Piotr Lukasz Rutkowski
The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue Sarcomas. Cancers 13 (6) (2021)
Mateusz Jacek Spałek, Anna Małgorzata Czarnecka, Piotr Lukasz Rutkowski
The Management of Radiation-Induced Sarcomas: A Cohort Analysis from a Sarcoma Tertiary Center. Journal of clinical medicine 10 (4) (2021)
Karolina Stachyra, Monika Dudzisz-Śledź, Elżbieta Bylina, Anna Szumera-Ciećkiewicz, Mateusz Jacek Spałek, Ewa Bartnik, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. International journal of molecular sciences 22 (12) (2021)
Kamil Jozef Synoradzki, Ewa Bartnik, Anna Małgorzata Czarnecka, Michał Fiedorowicz, Wiktoria Firlej, Anna Brodziak, Agnieszka Stasinska, Piotr Lukasz Rutkowski, Paweł Grieb
TP53 in Biology and Treatment of Osteosarcoma. Cancers 13 (17) (2021)
Ewa Paszkiewicz-Kozik, Agnieszka Paziewska, Maria Kulecka, Michalina Dabrowska, Anna Kluska, Aneta Bałabas, Magdalena Piątkowska, Filip Ambrozkiewicz, Joanna Tajer, Włodzimierz Osiadacz, Joanna Romejko-Jarosinska, Martyna Kotarska, Natalia Zeber-Lubecka, Jakub Karczmarski, Lidia Popławska, Michal Mikula, Piotr Lukasz Rutkowski, Jan Walewski, Jerzy Ostrowski
Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs. BioMed research international 2021 (2021)
Mateusz Jacek Spałek, Jan Poleszhuk, Anna Małgorzata Czarnecka, Monika Dudzisz-Śledź, Aleksandra Napieralska, Jacek Matysiakiewicz, Marzanna Chojnacka, Anna Raciborska, Aleksandra Sztuder, Adam Maciejczyk, Agata Szulc, Tomasz Skora, Bozena Cybulska-Stopa, Tomasz Winiecki, Joanna Kaźmierska, Bartlomiej Tomasik, Jacek Fijuth, Piotr Lukasz Rutkowski
Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis. Cells 10 (2) (2021)
Aneta Maria Borkowska, Anna Szumera-Ciećkiewicz, Maria Chraszczewska, Kamil Sokół, Tomasz Goryń, Piotr Lukasz Rutkowski
Clinical Significance of Tumor Microenvironment in Acral Melanoma: A Large Single-Institution Study of Caucasians. Journal of clinical medicine 10 (7) (2021)
Piotr Lukasz Rutkowski, Piotr Rutkowski
An update on the safety of nivolumab for the treatment of advanced melanoma. Expert opinion on drug safety 19 (4) (2021)
Canan Güvenç, Asier Antoranz, Anna Szumera-Ciećkiewicz, Pawel P Teterycz, Piotr Lukasz Rutkowski, Robert V Rawson, Richard A Scolyer, John F Thompson, Julia Newton-Bishop, Marguerite Stas, Veerle Boecxstaens, Oliver Bechter, Jurgen Vercauteren, Marjan Garmyn, Joost van den Oord, Francesca Maria Bosisio
Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas. International journal of molecular sciences 22 (19) (2021)
Che-Jui Lee, Elodie Modave, Bram Boeckx, Silvia Stacchiotti, Piotr Lukasz Rutkowski, Jean Yves Blay, Maria Debiec-Rychter, Raf M E Sciot, Diether Lambrechts, Agnieszka Wozniak, Patrick Schöffski
Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial. Cancers 13 (23) (2021)
Jedd D Wolchok, Vanna Chiarion Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Lukasz Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O Butler, Andrew Hill, Ivan Marquez-Rodas, John B A G Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Celeste Lebbè, Grant A McArthur, Paolo Antonio Ascierto, Gregory A Daniels, Georgina V Long, Tuba Bas, Corey Ritchings, James M G Larkin, Frank Stephen Hodi
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Paulina Jagodzińska-Mucha, Anna Raciborska, Hanna Kosela-Paterczyk, Katarzyna Kozak, Katarzyna Bilska, Tomasz Świtaj, Sławomir Falkowski, Anna Dawidowska, Piotr Lukasz Rutkowski, Iwona Ługowska
Age as a Prognostic Factor in Patients with Ewing Sarcoma-The Polish Sarcoma Group Experience. Journal of clinical medicine 10 (16) (2021)
Piotr Lukasz Rutkowski, Alice Indini, Matilde De Luca, Barbara Merelli, Anna Mariuk-Jarema, Pawel Teterycz, Pawel Rogala, Iwona Lugowska, Bozena Cybulska-Stopa, Alice Labianca, Lorenza Di Guardo, Michele Del Vecchio, Jacopo Pigozzo, Giovanni Randon, Francesca Corti, Carlo Alberto Tondini, Eliana Rulli, Mario Mandala
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study. Journal for immunotherapy of cancer 8 (2) (2021)
Paolo Antonio Ascierto, Michele Del Vecchio, Andrzej Mackiewicz, Caroline Robert, Vanna Chiarion-Sileni, Ana Arance, Céleste Lebbé, Inge Marie Svane, Catriona McNeil, Piotr Lukasz Rutkowski, Carmen Loquai, Laurent Mortier, Omid Hamid, Lars Bastholt, Brigitte Dreno, Dirk Schadendorf, Claus Garbe, Marta Nyakas, Jean-Jacques Grob, Luc Thomas, Gabriella Liszkay, Michael Smylie, Christoph Hoeller, Virginia Ferraresi, Florent Grange, Ralf Gutzmer, Joanna Pikiel, Fareeda Hosein, Burcin Simsek, Michele Maio
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma. Journal for immunotherapy of cancer 8 (1) (2021)
Aleksandra Sobiborowicz, Tomasz Świtaj, Pawel P Teterycz, Mateusz Jacek Spałek, Anna Szumera-Ciećkiewicz, Michał Wągrodzki, Marcin Zdzienicki, Anna Małgorzata Czarnecka, Piotr Lukasz Rutkowski
Feasibility and Long-Term Efficacy of PEComa Treatment-20 Years of Experience. Journal of clinical medicine 10 (10) (2021)
Iga Płachta, Marcin Kleibert, Anna Małgorzata Czarnecka, Mateusz Jacek Spałek, Anna Szumera-Ciećkiewicz, Piotr Lukasz Rutkowski
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation. International journal of molecular sciences 22 (9) (2021)
Agnieszka E Zając, Sylwia Kopeć, Bartlomiej Szostakowski, Mateusz Jacek Spałek, Michał Fiedorowicz, Elżbieta Bylina, Paulina Filipowicz, Anna Szumera-Ciećkiewicz, Andrzej Tysarowski, Anna Małgorzata Czarnecka, Piotr Lukasz Rutkowski
Chondrosarcoma-from Molecular Pathology to Novel Therapies. Cancers 13 (10) (2021)
Iga Płachta, Marcin Kleibert, Anna Małgorzata Czarnecka, Mateusz Jacek Spałek, Anna Szumera-Ciećkiewicz, Piotr Lukasz Rutkowski
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation. International journal of molecular sciences 22 (10) (2021)
Tomasz Świtaj, Aleksandra Sobiborowicz, Pawel P Teterycz, Anna Klimczak, Donata Makuła, Michał Wągrodzki, Anna Szumera-Ciećkiewicz, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Efficacy of Sirolimus Treatment in PEComa-10 Years of Practice Perspective. Journal of clinical medicine 10 (16) (2021)
Piotr Lukasz Rutkowski, Patrick Pauwels, Joseph Kerger, Bart Jacobs, Geert Maertens, Valerie Gadeyne, Anne Thielemans, Katrien de Backer, Bart Neyns
Characterization and Clinical Utility of BRAFV600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma. Cancers 13 (14) (2021)
Agnieszka E Zając, Sylwia Katarzyna Król, Piotr Lukasz Rutkowski, Anna Małgorzata Czarnecka
Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype. Cancers 13 (6) (2021)
Hanna Kosela-Paterczyk, Pawel P Teterycz, Mateusz Jacek Spałek, Aneta Borkowska, Anna Zawadzka, Michał Wągrodzki, Anna Szumera-Ciećkiewicz, Tadeusz Morysiński, Tomasz Świtaj, Iwona Ługowska, Patrycja Castaneda-Wysocka, Marcin Zdzienicki, Tomasz Goryń, Piotr Lukasz Rutkowski
Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall. Cancers 13 (12) (2021)
Anna Małgorzata Czarnecka, Krzysztof Ostaszewski, Aneta Borkowska, Anna Szumera-Ciećkiewicz, Katarzyna Kozak, Tomasz Świtaj, Paweł Rogala, Iwona Kalinowska, Hanna Kosela-Paterczyk, Konrad Zaborowski, Pawel P Teterycz, Andrzej Tysarowski, Donata Makuła, Piotr Lukasz Rutkowski
Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive Melanoma. Cancers 14 (1) (2021)
Katarzyna Kozak, Pawel P Teterycz, Tomasz Świtaj, Hanna Kosela-Paterczyk, Sławomir Falkowski, Tadeusz Morysiński, Ewa Bartnik, Anna Małgorzata Czarnecka, Michał Wągrodzki, Iwona Ługowska, Piotr Lukasz Rutkowski
The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma. Journal of clinical medicine 9 (10) (2020)

Piotr Lukasz Rutkowski.css-eqlu8i{font-size:small;padding-left:4px;} (Piotr Rutkowski, Anna M Czarnecka, Piotr Ł Rutkowski, Piotr R Rutkowski, Piotr L Rutkowski, Piotr Łukasz Rutkowski)

Publication Activity (10 Years)

Top Topics

Top Venues

Piotr Lukasz Rutkowski (Piotr Rutkowski, Anna M Czarnecka, Piotr Ł Rutkowski, Piotr R Rutkowski, Piotr L Rutkowski, Piotr Łukasz Rutkowski)